Glutamate-based Therapies for Psychiatric Disorders
Both metabotropic and ionotropic glutamate receptors present attractive “druggable” targets in treating disorders of the central nervous system. There has been a dramatic shift in the focus of glutamate-based therapies away from neurologic disorders such as stroke and traumatic brain injury to the t...
| Corporate Author: | SpringerLink (Online service) |
|---|---|
| Other Authors: | Skolnick, Phil (Editor) |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Basel :
Birkhäuser Basel : Imprint: Birkhäuser,
2010.
|
| Series: | Milestones in Drug Therapy
|
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
Similar Items
-
Biologics to Treat Substance Use Disorders Vaccines, Monoclonal Antibodies, and Enzymes /
Published: (2016) -
Adherence to Antipsychotics in Schizophrenia
by: Sacchetti, Emilio, et al.
Published: (2014) -
Placebo
Published: (2014) -
Anxiety and Anxiolytic Drugs
Published: (2005) -
Behavioral Neurobiology of Depression and Its Treatment
Published: (2013)